Clinical Trial Update: A Long-term Extension Study of Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension. [Phase 4]

View source ↗

Summary

This document describes a Phase 4 long-term extension study of riociguat in patients with symptomatic pulmonary arterial hypertension. It aims to assess long-te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Pulmonary Hypertension

Drugs mentioned

• Riociguat (riociguat)

Snippet

Sponsor: Bayer | Conditions: Hypertension, Pulmonary | Phase 4 | Status: COMPLETED